Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 424B5 Offering Prospectus
  2. EFFECT Other Notice of Effectiveness
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 8-K Event Regulation FD disclosure
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Regulation FD disclosure
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 17 of 30 · 584 filings